We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microsoft and GE Complete Joint Venture to Form New Company

By HospiMedica International staff writers
Posted on 03 Jul 2012
GE Healthcare (Chalfont St. More...
Giles, UK), through its healthcare information technology (IT) business, and Microsoft Corp. (Redmond, WA, USA) reported that they have completed the formation of Caradigm, a 50-50 joint venture geared at enabling health systems and professionals to use real time, organization-wide intelligence to improve healthcare quality and the patient experience.

Caradigm will develop and market an open healthcare intelligence platform and collaborative clinical applications focused on enabling better population health management to improve outcomes and the economics of health and wellness. Plans for the joint venture were first announced on December 7, 2011, and the final agreement was completed on June 1, 2012.

The Caradigm board of directors and leadership team, announced in February, is composed of executives from both parent companies. Caradigm will be led by CEO Michael Simpson, who joins the company from GE Healthcare. Moreover, the companies today announced the appointment of Lauren Salata as chief financial officer and Michael Willingham as quality assurance and regulatory affairs executive for Caradigm. Ms. Salata previously served as the chief financial officer (CFO) and compliance officer of Care Innovations, an Intel and GE company based in Roseville (CA, USA). Mr. Willingham joins Caradigm from Philips Healthcare in Bothell (WA, USA), where he served as senior director of quality and regulatory affairs.

“The combination of people and technology from GE Healthcare and Microsoft will allow us to drive the dramatic change that is needed in healthcare,” Mr. Simpson said. “By forming Caradigm, we can offer innovative healthcare solutions, including an open platform and tools that enable software developers around the world to address the complexities of population health today.”

Caradigm will be located at City Center Bellevue in Bellevue (WA, USA), with significant presence in Salt Lake City (UT, USA), Andover (MA, USA), Chevy Chase (MD, USA), and other cities worldwide.

GE Healthcare provides expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions services. In addition, the company partners with healthcare leaders to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Related Links:

GE Healthcare
Microsoft
Caradigm



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.